Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19

NCT04346329 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study did not get financed. Never got started.

Conditions

COVID

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo oral tablet

Sponsor

Universidad Nacional de Colombia

Collaborators

[object Object]